Duke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi: 10.1001/jamacardio.2021.2828.
Vaccine-associated myocarditis is an unusual entity that has been described for the smallpox vaccine, but only anecdotal case reports have been described for other vaccines. Whether COVID-19 vaccination may be linked to the occurrence of myocarditis is unknown.
To describe a group of 7 patients with acute myocarditis over 3 months, 4 of whom had recent messenger RNA (mRNA) COVID-19 vaccination.
DESIGN, SETTING, AND PARTICIPANTS: All patients referred for cardiovascular magnetic resonance imaging at Duke University Medical Center were asked to participate in a prospective outcomes registry. Two searches of the registry database were performed: first, to identify patients with acute myocarditis for the 3-month period between February 1 and April 30 for 2017 through 2021, and second, to identify all patients with possible vaccine-associated myocarditis for the past 20 years. Once patients with possible vaccine-associated myocarditis were identified, data available in the registry were supplemented by additional data collection from the electronic health record and a telephone interview.
mRNA COVID-19 vaccine.
Occurrence of acute myocarditis by cardiovascular magnetic resonance imaging.
In the 3-month period between February 1 and April 30, 2021, 7 patients with acute myocarditis were identified, of which 4 occurred within 5 days of COVID-19 vaccination. Three were younger male individuals (age, 23-36 years) and 1 was a 70-year-old female individual. All 4 had received the second dose of an mRNA vaccine (2 received mRNA-1273 [Moderna], and 2 received BNT162b2 [Pfizer]). All presented with severe chest pain, had biomarker evidence of myocardial injury, and were hospitalized. Coincident testing for COVID-19 and respiratory viruses provided no alternative explanation. Cardiac magnetic resonance imaging findings were typical for myocarditis, including regional dysfunction, late gadolinium enhancement, and elevated native T1 and T2.
In this study, magnetic resonance imaging findings were found to be consistent with acute myocarditis in 7 patients; 4 of whom had preceding COVID-19 vaccination. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.
疫苗相关性心肌炎是一种罕见的疾病,已经在天花疫苗中得到描述,但其他疫苗仅描述了一些偶发病例报告。COVID-19 疫苗接种是否与心肌炎的发生有关尚不清楚。
描述 7 例在 3 个月内发生的急性心肌炎患者,其中 4 例在近期接受了信使 RNA(mRNA)COVID-19 疫苗接种。
设计、地点和参与者:所有在杜克大学医学中心接受心血管磁共振成像检查的患者均被要求参与一项前瞻性结局登记研究。对登记数据库进行了两次搜索:第一次是在 2017 年至 2021 年 2 月 1 日至 4 月 30 日的 3 个月期间,确定急性心肌炎患者;第二次是在过去 20 年中确定所有可能与疫苗相关的心肌炎患者。一旦确定了可能与疫苗相关的心肌炎患者,就会从登记处的数据中补充额外的数据收集,来自电子健康记录和电话访谈。
mRNA COVID-19 疫苗。
通过心血管磁共振成像确定急性心肌炎的发生。
在 2021 年 2 月 1 日至 4 月 30 日的 3 个月期间,确定了 7 例急性心肌炎患者,其中 4 例发生在 COVID-19 疫苗接种后 5 天内。这 3 例是年轻男性(年龄 23-36 岁),1 例是 70 岁女性。所有 4 例均接受了第二剂 mRNA 疫苗(2 例接受了 mRNA-1273[Moderna],2 例接受了 BNT162b2[辉瑞])。所有患者均出现严重胸痛,有心肌损伤的生物标志物证据,并住院治疗。同时进行的 COVID-19 和呼吸道病毒检测未提供其他解释。心脏磁共振成像结果与心肌炎一致,包括区域性功能障碍、晚期钆增强以及升高的原生 T1 和 T2 值。
在这项研究中,7 例患者的磁共振成像结果被发现与急性心肌炎一致,其中 4 例患者在 COVID-19 疫苗接种前发生。需要进一步调查以确定 COVID-19 疫苗接种与心肌炎之间的关联。